These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6323909)

  • 1. Cyanamide-induced liver injury. A predictable lesion.
    Vazquez JJ; Guillen FJ; Zozaya J; Lahoz M
    Liver; 1983 Aug; 3(4):225-30. PubMed ID: 6323909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis induced by drugs used as alcohol aversion therapy.
    Vázquez JJ; Diaz de Otazu R; Guillen FJ; Zozaya J; Pardo FJ
    Diagn Histopathol; 1983; 6(1):29-37. PubMed ID: 6307616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan).
    Thomsen P; Reinicke V
    Liver; 1981 Mar; 1(1):67-73. PubMed ID: 6294436
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
    Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
    Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanamide-induced liver injury in alcoholics.
    Vázquez JJ; Cervera S
    Lancet; 1980 Feb; 1(8164):361-2. PubMed ID: 6101808
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural hepatic changes associated with cyanamide treatment: cholangiolar proliferation, fibrosis and cirrhosis.
    Moreno A; Vazquez JJ; Ruizdel Arbol L; Guillen FJ; Colina F
    Liver; 1984 Feb; 4(1):15-21. PubMed ID: 6321877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyanamide hepatotoxicity. Incidence and clinico-pathological features.
    Bruguera M; Parés A; Heredia D; Rodés J
    Liver; 1987 Aug; 7(4):216-22. PubMed ID: 3683093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyanamide and disulfiram in effects on liver function.
    Tamai H; Yokoyama A; Okuyama K; Takahashi H; Maruyama K; Suzuki Y; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):97S-99S. PubMed ID: 10803789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
    Bruguera M; Lamar C; Bernet M; Rodés J
    Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanamide-induced liver cell injury. Experimental study in the rat.
    Guillen FJ; Vazquez JJ
    Lab Invest; 1984 Apr; 50(4):385-93. PubMed ID: 6323849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver function in alcoholic patients treated with cyanamide].
    Borja Villegas J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(3):223-5. PubMed ID: 6485916
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide.
    Hashimoto K; Hoshii Y; Takahashi M; Mitsuno S; Hanai N; Watanabe Y; Ishihara T
    Histopathology; 2001 Jul; 39(1):60-5. PubMed ID: 11454045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ground-glass hepatocellular inclusions are associated with polypharmacy.
    Lu HC; González IA; Byrnes K
    Ann Diagn Pathol; 2021 Jun; 52():151740. PubMed ID: 33836412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver lesion caused by cyanamide. Study of a case and review of the bibliography].
    Sáenz de Santa María J; Moreno Casado J; Sánchez Satrústegui JF
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):417-20. PubMed ID: 3291022
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyanamide, ethanol, and liver cell inclusion bodies.
    Obach VR; Valles PJ; Rives FA
    Lab Invest; 1985 Jul; 53(1):116-7. PubMed ID: 2989615
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyanamide and its calcium form: do they differ with respect to their action on the liver cell? Experimental study in the rat.
    Valérdiz S; Vázquez JJ
    Appl Pathol; 1989; 7(6):344-9. PubMed ID: 2640894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyanamide hepatotoxicity: various forms of presentation. Apropos of 2 cases].
    Caballería Rovira E; Aragó López JV; Massó Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Clin Esp; 1986 Jun; 179(2):79-81. PubMed ID: 2942986
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression mechanism of cyanamide-induced inclusion bodies in the rat: a useful experimental pattern to study the beta-glycogen metabolization of hepatocytes.
    Idoate MA; Vázquez JJ
    Int J Exp Pathol; 1992 Dec; 73(6):699-708. PubMed ID: 1337264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ground-glass hepatocytes: light and electron microscopy. Characterization of the different types.
    Vázquez JJ
    Histol Histopathol; 1990 Jul; 5(3):379-86. PubMed ID: 1966881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.